A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts
The coronavirus disease 2019 (COVID-19) pandemic has illustrated the critical need for effective prophylactic vaccination to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Intranasal vaccination is an attractive approach for preventing COVID-19 as the nasal mucos...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2022-11-01
|
| Serier: | Human Vaccines & Immunotherapeutics |
| Fag: | |
| Online adgang: | http://dx.doi.org/10.1080/21645515.2022.2127292 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
